Recently, Mendillo et al (7) reported that hyperphosphorylation of HSF1/S326, which is upregulated in breast cancer compared with the normal counterparts, was used as a biomarker to indicate HSF1 activation in breast cancer. This evidence concerns the gene HSF1 and breast cancer.